IIRM Holdings India Limited received trading approval from the Bombay Stock Exchange (BSE) for 15,59,883 equity shares allotted on a preferential basis. The shares will commence trading on the exchange effective October 9, 2026.

The allotment was made to non-promoter investors at a premium of ₹138.28 per share. Each equity share has a face value of ₹5. The total issue price per share stands at ₹143.28, combining the face value and the premium.

Allotment details

The company filed the intimation with the BSE and the Calcutta Stock Exchange pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The specific securities involved bear distinctive numbers from 68144251 to 69704133.

Regulatory compliance

The approval was granted by Nitinkumar Pujari, Assistant Vice President at the BSE, referencing Notice No. 20261008-24 dated October 8, 2026. The company’s Company Secretary & Compliance Officer, V. Sri Lakshmi, submitted the application and subsequent submissions required for the listing.

This corporate action follows the company's rebranding from Sudev Industries Limited to IIRM Holdings India Limited. The registered office is located in Secunderabad, Hyderabad, Telangana.

IIRM Holdings India Limited received a disclosure from Carpediem Capital Partners Fund II on September 12, 2026, regarding its acquisition of equity shares and convertible warrants under a preferential issue.

The filing was made pursuant to Regulation 29(1) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. It confirms the details of the allotment approved by the company's Board of Directors on September 11, 2026, following shareholder approval at the 33rd Annual General Meeting held on August 27, 2026.

Acquisition Details

Carpediem Capital Partners Fund II acquired 11,67,295 equity shares and 66,14,671 convertible warrants through the preferential allotment. The acquisition does not involve any shares encumbered by pledge or lien.

Each warrant entitles the holder to subscribe to one fully paid-up equity share with a face value of ₹5. The warrants are exercisable within 18 months from the date of allotment. An upfront payment equivalent to 25% of the issue price was paid at the time of allotment, with the balance payable upon exercise.

Post-Issuance Holding

Following this acquisition, Carpediem Capital Partners Fund II holds a total stake of 9.9% on a fully diluted basis. The fund is categorized as a non-promoter investor. This aligns with the earlier board approval which noted that Carpediem emerged as the largest single beneficiary of the ₹149 crore preferential issue.

The total voting capital of IIRM Holdings increased from ₹34,07,21,250 before the acquisition to ₹34,85,20,665 after the issuance of new equity shares. The total diluted share capital stands at ₹39,27,17,330 post-acquisition.